Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 160


Phenotypic and functional analysis of human SLC26A6 variants in patients with familial hyperoxaluria and calcium oxalate nephrolithiasis.

Monico CG, Weinstein A, Jiang Z, Rohlinger AL, Cogal AG, Bjornson BB, Olson JB, Bergstralh EJ, Milliner DS, Aronson PS.

Am J Kidney Dis. 2008 Dec;52(6):1096-103. doi: 10.1053/j.ajkd.2008.07.041. Epub 2008 Oct 31.


Species differences in Cl- affinity and in electrogenicity of SLC26A6-mediated oxalate/Cl- exchange correlate with the distinct human and mouse susceptibilities to nephrolithiasis.

Clark JS, Vandorpe DH, Chernova MN, Heneghan JF, Stewart AK, Alper SL.

J Physiol. 2008 Mar 1;586(5):1291-306. doi: 10.1113/jphysiol.2007.143222. Epub 2008 Jan 3.


Primary Hyperoxaluria Type 1.

Milliner DS, Harris PC, Cogal AG, Lieske JC.

In: Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Stephens K, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2018.
2002 Jun 19 [updated 2017 Nov 30].


Urinary oxalate excretion in urolithiasis and nephrocalcinosis.

Neuhaus TJ, Belzer T, Blau N, Hoppe B, Sidhu H, Leumann E.

Arch Dis Child. 2000 Apr;82(4):322-6.


Calcium oxalate urolithiasis in mice lacking anion transporter Slc26a6.

Jiang Z, Asplin JR, Evan AP, Rajendran VM, Velazquez H, Nottoli TP, Binder HJ, Aronson PS.

Nat Genet. 2006 Apr;38(4):474-8. Epub 2006 Mar 12.


Primary hyperoxaluria type 2 in children.

Johnson SA, Rumsby G, Cregeen D, Hulton SA.

Pediatr Nephrol. 2002 Aug;17(8):597-601. Epub 2002 Jun 6.


Phenotype-Genotype Correlations and Estimated Carrier Frequencies of Primary Hyperoxaluria.

Hopp K, Cogal AG, Bergstralh EJ, Seide BM, Olson JB, Meek AM, Lieske JC, Milliner DS, Harris PC; Rare Kidney Stone Consortium.

J Am Soc Nephrol. 2015 Oct;26(10):2559-70. doi: 10.1681/ASN.2014070698. Epub 2015 Feb 2.


Primary hyperoxaluria type III gene HOGA1 (formerly DHDPSL) as a possible risk factor for idiopathic calcium oxalate urolithiasis.

Monico CG, Rossetti S, Belostotsky R, Cogal AG, Herges RM, Seide BM, Olson JB, Bergstrahl EJ, Williams HJ, Haley WE, Frishberg Y, Milliner DS.

Clin J Am Soc Nephrol. 2011 Sep;6(9):2289-95. doi: 10.2215/CJN.02760311.


Role of SLC26A6-mediated Cl⁻-oxalate exchange in renal physiology and pathophysiology.

Aronson PS.

J Nephrol. 2010 Nov-Dec;23 Suppl 16:S158-64. Review.


A test of the hypothesis that oxalate secretion produces proximal tubule crystallization in primary hyperoxaluria type I.

Worcester EM, Evan AP, Coe FL, Lingeman JE, Krambeck A, Sommers A, Phillips CL, Milliner D.

Am J Physiol Renal Physiol. 2013 Dec 1;305(11):F1574-84. doi: 10.1152/ajprenal.00382.2013. Epub 2013 Oct 2.


Assessment of Urine Proteomics in Type 1 Primary Hyperoxaluria.

Brooks ER, Hoppe B, Milliner DS, Salido E, Rim J, Krevitt LM, Olson JB, Price HE, Vural G, Langman CB.

Am J Nephrol. 2016;43(4):293-303. doi: 10.1159/000445448. Epub 2016 May 3.


Glyoxylate reductase activity in blood mononuclear cells and the diagnosis of primary hyperoxaluria type 2.

Knight J, Holmes RP, Milliner DS, Monico CG, Cramer SD.

Nephrol Dial Transplant. 2006 Aug;21(8):2292-5. Epub 2006 Apr 5.


A double mutation in AGXT gene in families with primary hyperoxaluria type 1.

Kanoun H, Jarraya F, Hadj Salem I, Mahfoudh H, Chaabouni Y, Makni F, Hachicha J, Fakhfakh F.

Gene. 2013 Dec 1;531(2):451-6. doi: 10.1016/j.gene.2013.08.083. Epub 2013 Sep 5.


Loss of Cystic Fibrosis Transmembrane Regulator Impairs Intestinal Oxalate Secretion.

Knauf F, Thomson RB, Heneghan JF, Jiang Z, Adebamiro A, Thomson CL, Barone C, Asplin JR, Egan ME, Alper SL, Aronson PS.

J Am Soc Nephrol. 2017 Jan;28(1):242-249. doi: 10.1681/ASN.2016030279. Epub 2016 Jun 16.


Extracellular nucleotides inhibit oxalate transport by human intestinal Caco-2-BBe cells through PKC-δ activation.

Amin R, Sharma S, Ratakonda S, Hassan HA.

Am J Physiol Cell Physiol. 2013 Jul 1;305(1):C78-89. doi: 10.1152/ajpcell.00339.2012. Epub 2013 Apr 17.


N-glycosylation critically regulates function of oxalate transporter SLC26A6.

Thomson RB, Thomson CL, Aronson PS.

Am J Physiol Cell Physiol. 2016 Dec 1;311(6):C866-C873. doi: 10.1152/ajpcell.00171.2016. Epub 2016 Sep 28.


Molecular aetiology of primary hyperoxaluria and its implications for clinical management.

Danpure CJ, Rumsby G.

Expert Rev Mol Med. 2004 Jan 9;6(1):1-16. Review.


Roux-en-Y gastric bypass is associated with early increased risk factors for development of calcium oxalate nephrolithiasis.

Duffey BG, Pedro RN, Makhlouf A, Kriedberg C, Stessman M, Hinck B, Ikramuddin S, Kellogg T, Slusarek B, Monga M.

J Am Coll Surg. 2008 Jun;206(6):1145-53. doi: 10.1016/j.jamcollsurg.2008.01.015. Epub 2008 Apr 14.


Supplemental Content

Support Center